期刊簡介預計審稿時間： 約2.1月

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.

Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease.

《臨床癌癥研究》發(fā)表創(chuàng)新的臨床和轉化癌癥研究，將實驗室和臨床聯(lián)系起來。該期刊特別關注評估新療法的臨床試驗，以及藥理學研究、預測治療反應或耐藥性的分子改變或生物標記物。該期刊還優(yōu)先考慮可能進行臨床試驗的新藥和分子靶向藥物的實驗室和動物研究，以及針對癌變、惡性表型進展和轉移性疾病的靶向機制的研究。

具體感興趣的領域包括靶向治療的臨床和轉化研究；藥物敏感性和耐藥性的機制；藥物遺傳學和藥物基因組學；個性化醫(yī)療；生物信息學和生物統(tǒng)計學的新應用；免疫療法和臨床免疫學；基因治療；放射生物學和放射腫瘤學；人類腫瘤的大規(guī)模分子表征；診斷性生物標記物；創(chuàng)新成像和其他可能適用于臨床研究的新方法；臨床遺傳學；以及最小疾病的檢測。

《Clinical Cancer Research》(臨床癌癥研究)編輯部通訊方式為AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404。如果您需要協(xié)助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。